Search results
Nearly 1.9 million cases of water impacted by FDA recall
KSNT Topeka via Yahoo News· 16 hours agoTOPEKA (KSNT) – The Food and Drug Administration (FDA) says a bottled water producer is recalling...
What to know about the blood test to detect colon cancer recommended by an FDA panel
ABC News via Yahoo News· 16 hours agoA blood test to screen for colorectal cancer is one step closer to receiving approval from the U.S....
Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings
Market Watch· 5 days agojumped more than 30% Monday morning after the health and wellness platform said it would offer...
3 High-Flying Stocks That Could Soar Even More
Motley Fool via Yahoo Finance· 40 minutes agoSome Wall Street analysts predict that the market for MASH/NASH treatments could be worth more than $100 billion annually. A Food and Drug Administration
Exact Sciences stock drops as Guardant Health test supported by FDA panel By Investing.com
Investing.com· 21 hours agoExact Sciences (NASDAQ:EXAS) stock dropped Friday after news that the Molecular and Clinical...
FDA advisory committee reviews Novo Nordisk insulin icodec for T1D
Pharmaceutical Technology via Yahoo Finance· 23 hours agoThe US Food and Drug Administration’s (FDA) Endocrinologic and Metabolic Drugs Advisory Committee is...
Guardant Health Jumps — As Exact Sciences Slumps — On A Key FDA Move For Blood Tests
Investor's Business Daily· 15 hours agoGuardant Health stock jumped Friday after a Food and Drug Administration panel recommended the...
FDA grants IND clearance for Abdera’s Phase I cancer therapy trial
Clinical Trials Arena via Yahoo Finance· 23 hours agoThe US Food and Drug Administration (FDA) has granted clearance for Abdera Therapeutics'...
Fact Check: We Looked Into the Claim that Breyer's Ice Cream Is Now Called 'Frozen Dessert' Because...
Snopes via Yahoo News· 9 hours agoMay 2024, a post on Facebook claimed that ice cream manufacturer Breyer's no longer sold ice cream,...
FDA panel backs Guardant’s blood test for colon cancer
MedTech Dive via Yahoo Finance· 1 day agoWilliam Blair analyst Andrew Brackmann said the FDA appears on its way to approving Shield. Still,...
